Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04431635
Brief Title: Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma

First Submitted : June 11, 2020
First Submitted that Met QC Criteria : June 12, 2020
First Posted : June 16, 2020

Last Update Submitted that Met QC Criteria : November 13, 2020
Last Update Posted : November 16, 2020